ACICLOVIR ACCORD
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1782288
Name of medicinal product:
ACICLOVIR ACCORD
Active substances:
Aciclovir
Estonian
,
English
,
Latin
ATC code:
J05AB01
Dosage form:
concentrate for solution for infusion
Route of administration:
intravenous use
Strengh:
25mg 1ml
Amount in package:
40ml 10TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
is indicated for: the treatment and prophylaxis of herpes simplex infections - in patients undergoing bone marrow transplantations - during remission-induction therapy of patients with acute leukemia the treatment of - primary and recurring varicella zoster infections in immunocompromised patients - severe shingles (recurring varicella zoster infections) in patients with a normal immune response. - Severe initial genital herpes - Herpes simplex encephalitis - Herpes neonatorum
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated 06 June 2022)
Package information leaflet (PIL):
EST
(last updated 06 June 2022)
Labelling:
(last updated 19 May 2020)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Accord Healthcare B.V.
Marketing authorization number:
1005720
Marketing authorization issued on:
19 May 2020
Marketing authorization expires on:
19 May 2025
Marketing authorization procedure type:
Decentralised
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Perscription conditions and restrictions
Description
Additional condition
Hambaarstil on õigus välja kirjutada
Entry/Changing date: 17 November 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription